Roche Holding AG hired a senior executive from rival Novo Nordisk A/S as the Swiss drugmaker prepares to enter the hyper-competitive market for obesity drugs. Morten Lammert will join Roche as its ...

Roche has put forward a new approach to genetic analysis, which it describes as sequencing-by-expansion—a proprietary method that pulls apart the DNA molecule and amplifies the signal of each ...

Proactiv Skin Smoothing Exfoliator and La Roche-Posay Effaclar Duo Dual Action Acne Treatment. The full list and lot numbers was posted online Tuesday. “Even with daily use of these products for ...

Here's why La Roche-Posay is pulling its Effaclar Duo Acne Spot Treatment from retail shelves. La Roche-Posay is a brand under the L'Oreal Group umbrella. A La Roche-Posay spokesperson confirmed ...

Acne creams from retailers including Walgreens, La Roche-Posay and Proactiv have been ... in the U.S. including detergents, dyes and drugs, according to the U.S. Centers for Disease Control ...

F. Hoffmann-La Roche, one of the world’s largest biotechnology companies, announced on Thursday that it will establish an Innovation Center on Harvard’s Enterprise Research Campus in Allston.

U.S. health officials are asking retailers to pull a small number of acne creams from their store shelves after government ...

Proactiv Skin Smoothing Exfoliator and La Roche-Posay Effaclar Duo Dual Action Acne Treatment. The full list and lot numbers was posted online Tuesday. The FDA stressed consumers face little risk ...

LONDON — Looking to expand its obesity offerings, Roche on Wednesday said it had partnered with Zealand Pharma to license an experimental weight loss drug for $1.65 billion in upfront cash.

By Lisa Lerer The country’s largest manufacturer of abortion pills is wading into the first major legal battle over abortion of President Trump’s second term. The company, GenBioPro ...

Swiss pharmaceutical company Roche announced Friday it will open an innovation center in the Harvard University Enterprise Research Campus in Allston that could employ hundreds. The Roche ...

As for Roche CEO Thomas Schinecker, his 2024 remuneration reached slightly above 10 million Swiss francs ... Recently launched drugs Leqvio, Scemblix, Lutathera, Fabhalta and Pluvicto came ...